Stereoselective Metabolism of Omeprazole by Human Cytochrome P450 Enzymes (original) (raw)

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

Tommy Andersson

British Journal of Clinical Pharmacology, 1993

View PDFchevron_right

Identification of Residues 99, 220, and 221 of Human Cytochrome P450 2C19 as Key Determinants of Omeprazole Hydroxylase Activity

lee pedersen

Journal of Biological Chemistry, 1996

View PDFchevron_right

Omeprazole Coinduces Multiple Xenobiotic‐metabolizing Enzymes in the Rata

Khosrow Kashfi

Annals of the New York Academy of Sciences, 1995

View PDFchevron_right

The hydroxylation of omeprazole correlates with S -mephenytoin and proguanil metabolism

Selim Kortunay

European Journal of Clinical Pharmacology, 1997

View PDFchevron_right

Effect of clopidogrel on the hydroxylation and sulfoxidation of omeprazole: A single dose study in healthy human volunteers

Dr Abad Khan

EXCLI journal, 2017

View PDFchevron_right

Simultaneous determination of omeprazole, hydroxyomeprazole and omeprazole sulphone in human plasma by isocratic HPLC-DAD: application to the phenotyping of CYP2C19 and CYP3A4 in brazilian volunteers

Andre Arigony

Journal of the Brazilian Chemical Society, 2007

View PDFchevron_right

Comparative Effects of Rabeprazole and Omeprazole on the Inducibility of Cytochrome P450-1A and Cytochrome P450-3A Isoenzymes in Human Hepatocytes, and Effects on Cyclosporin Metabolism in Human Liver Microsomes

Patrick Maurel

Clinical Drug Investigation, 2000

View PDFchevron_right

Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers

Staffan Rosenborg

British Journal of Clinical Pharmacology, 2008

View PDFchevron_right

Induction of Cytochrome P-450 1A1 by Omeprazole in Human HepG2 Cells Is Protein Tyrosine Kinase-Dependent and Is Not Inhibited by α-Naphthoflavone

Anwar hossain

Archives of Biochemistry and Biophysics, 1998

View PDFchevron_right

CYP2C19- and CYP3A4-Dependent Omeprazole Metabolism in West Mexicans

Héctor González

The Journal of Clinical Pharmacology, 2003

View PDFchevron_right

Evidence of human metabolites of omeprazole and its structure elucidation by using HPLC-MS

Mohammad Hailat

Journal of Molecular Structure, 2021

View PDFchevron_right

Omeprazole: Effects on Oxidative Drug Metabolism in the Rat

Peter Dosen

Clinical and Experimental Pharmacology and Physiology, 1986

View PDFchevron_right

Omeprazole and aryl hydrocarbon hydroxylases: Should we be worried?

D. Kim Turgeon

Hepatology, 1991

View PDFchevron_right

Phenotype of CYP2C19 and CYP3A4 by determination of omeprazole and its two main metabolites in plasma using liquid chromatography with liquid–liquid extraction

Carlos Hoyo

Journal of Chromatography B, 2002

View PDFchevron_right

Ethoxy-, pentoxy-and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450

Richard Mayer

Biochemical …, 1985

View PDFchevron_right

Identification of the Cytochrome P450 Enzymes Involved in theN-Oxidation of Voriconazole

ruth hyland

Drug Metabolism and Disposition, 2003

View PDFchevron_right

Omeprazole limited sampling strategies to predict area under the concentration–time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping

Staffan Rosenborg

European Journal of Clinical Pharmacology, 2012

View PDFchevron_right

Sensitive quantification of omeprazole and its metabolites in human plasma by liquid chromatography–mass spectrometry

Ute Hofmann

Journal of Chromatography B, 2006

View PDFchevron_right

Improved procedure for quantitation of omeprazole and metabolites using reversed-phase high-performance liquid chromatography

Michael Amantea

Journal of Chromatography B: Biomedical Sciences and Applications, 1988

View PDFchevron_right

Kinetics of omeprazole degradation in the presence of 2‐mercaptoethanol

Ali Al-matar

International Journal of …, 2008

View PDFchevron_right

Inhibition of Human Cytochrome P450 Enzymes by 1,2-Dithiole-3-thione, Oltipraz and Its Derivatives, and Sulforaphane

André Guillouzo

Chemical Research in Toxicology, 2000

View PDFchevron_right

Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole

Tommy Andersson

Alimentary Pharmacology and Therapeutics, 2001

View PDFchevron_right

Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers

Adriana Rocha

British Journal of Clinical Pharmacology, 2010

View PDFchevron_right

Sensitive sulphur-specific detection of omeprazole metabolites in rat urine by high-performance liquid chromatography/inductively coupled plasma mass spectrometry

Lars Weidolf

Rapid Communications in Mass Spectrometry, 2004

View PDFchevron_right

Identification of the human cytochromes P450 catalysing the rate‐limiting pathways of gliclazide elimination

Benjamin Lewis

British journal of …, 2007

View PDFchevron_right

Hydroxylation index of omeprazole in relation to CYP2C19 polymorphism and sex in a healthy Iranian population

reza tahvilian

DARU Journal of Pharmaceutical Sciences, 2014

View PDFchevron_right

Cytochrome P 450 enzymes induced roles in pharamacokinetic and drug interaction

Pálma Porrogi

2016

View PDFchevron_right

Identification of the cytochrome P450 enzymes involved in theN-demethylation of sildenafil

ruth hyland

British Journal of Clinical Pharmacology, 2001

View PDFchevron_right

Metabolism of a 5HT6 Antagonist, 2-Methyl-1-(Phenylsulfonyl)-4-(Piperazin-1-yl)-1H-Benzo[d]imidazole (SAM-760): Impact of Sulfonamide Metabolism on Diminution of a Ketoconazole-Mediated Clinical Drug-Drug Interaction

Peter Lockwood

Drug Metabolism and Disposition, 2018

View PDFchevron_right

Effects of Omeprazole and Genetic Polymorphism of CYP2C19 on the Clopidogrel Active Metabolite

Nassim Djebli, Xavier Boulenc

Drug Metabolism and Disposition, 2012

View PDFchevron_right

Contribution of human cytochrome P -450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine

Patrick Maurel

British Journal of Pharmacology, 2003

View PDFchevron_right

Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine

Christoph Hiemke

Clinical Pharmacokinetics, 2017

View PDFchevron_right

Quantitative Prediction of the in Vivo Inhibition of Diazepam Metabolism by Omeprazole Using Rat Liver Microsomes and Hepatocytes

brian houston

Drug Metabolism and Disposition, 2004

View PDFchevron_right